OPTIMER PHARMACEUTICALS INC (OPTR) financial statements (2021 and earlier)

Company profile

Business Address 101 HUDSON STREET
JERSEY CITY, NJ 07302
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:7893 
Cash and cash equivalents7388 
Short-term investments55 
Other undisclosed cash, cash equivalents, and short-term investments(0)(0) 
Receivables911 
Inventory, net of allowances, customer advances and progress billings2722
Inventory2722 
Prepaid expense and other current assets23 
Other undisclosed current assets00 
Total current assets:115129 
Noncurrent Assets
Property, plant and equipment44 
Prepaid expense and other noncurrent assets11 
Deferred tax assets, net11 
Total noncurrent assets:66 
TOTAL ASSETS:121135 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3028 
Accounts payable34 
Accrued liabilities2724 
Deferred revenue and credits00 
Total current liabilities:3028 
Noncurrent Liabilities
Liabilities, other than long-term debt22 
Deferred revenue and credits11 
Accrued income taxes11 
Total noncurrent liabilities:22 
Total liabilities:3230 
Stockholders' equity
Stockholders' equity attributable to parent89105 
Common stock00 
Additional paid in capital399388 
Accumulated other comprehensive income00 
Accumulated deficit(310)(283) 
Total stockholders' equity:89105 
TOTAL LIABILITIES AND EQUITY:121135 

Income statement (P&L) ($ in millions)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues2019 
Revenue, net1917 
Cost of revenue(6)(7) 
Cost of goods and services sold(2)(2) 
Gross profit:1412 
Operating expenses(41)(44) 
Operating loss:(27)(31) 
Nonoperating income00 
Net loss available to common stockholders, diluted:(27)(31) 

Comprehensive Income ($ in millions)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net loss:(27)(31) 
Other comprehensive loss(0)(0) 
Comprehensive loss, net of tax, attributable to parent:(27)(31) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: